Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G10 | O15496 | 1/20 | 0.83 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.83 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.68 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.58 |
| ▸ | PARP10 | Q53GL7 | 8/20 | 0.57 |
| ▸ | PARP1 | P09874 | 3/20 | 0.52 |
| ▸ | TSHR | P16473 | 2/20 | 0.52 |
| ▸ | POLB | P06746 | 1/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.52 |
| ▸ | RECQL | P46063 | 1/20 | 0.52 |
| ▸ | BLM | P54132 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | PARP4 | Q9UKK3 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.52 |
| ▸ | PARP15 | Q460N3 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1719129 | 0.91 | PLA2G2A (1.00) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL12663746 | 0.89 | PLA2G10 (0.68) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL18455085 | 0.87 | PLA2G10 (0.66) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL23905177 | 0.87 | CYP17A1 (0.89) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL28396819 | 0.87 | PLA2G2A (0.92) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL6804938 | 0.84 | PARP10 (0.64) | PLA2G10PLA2G2ACYP17A1PARP10PARP15 | |
| SCHEMBL8213818 | 0.84 | PARP10 (0.78) | PLA2G10PLA2G2ACYP17A1KMT2APARP10 | |
| SCHEMBL22721356 | 0.84 | MAOB (0.67) | PLA2G10PLA2G2ACYP17A1ALDH1A1MAOB | |
| Terephthalamide SCHEMBL23774 | 0.83 | PARP1 (0.71) | PLA2G10PLA2G2AKMT2APARP10PARP1 | |
| SCHEMBL22284875 | 0.82 | CYP17A1 (1.00) | PLA2G10PLA2G2ACYP17A1TSHRCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3125033-B1 | LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2021-06-02 | — | — | EP | disclosed |
| EP-3179303-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2020-04-01 | — | — | EP | disclosed |
| EP-3133136-B1 | LIQUID CRYSTAL DISPLAY DEVICE | JNC CORP (JP) | 2019-08-07 | — | — | EP | disclosed |
| EP-3163368-B1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC CORP (JP) | 2019-06-26 | — | — | EP | disclosed |
| EP-3163368-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2017-05-03 | — | — | EP | disclosed |
| EP-3133136-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2017-02-22 | — | — | EP | disclosed |
| EP-3125033-A1 | LIQUID CRYSTAL DISPLAY ELEMENT | JNC Corporation (JP) | 2017-02-01 | — | — | EP | disclosed |
| WO-2003051347-A1 | USE OF UROKINASE RECEPTOR ANTAGONISTS TO MODULATE ISCHEMIAREPERFUSION INJURY | VLAAMS INTERUNIVERSITAIR INSTITUUT VOOR BIOTECHNOLOGIE VZW (BE) | 2003-06-26 | — | — | WO | disclosed |
| US-5792840-A | SUBSTITUTED GLUCOPYRANOSYL PHOSPHATES | SANKYO COMPANY, LIMITED (JP) | 1998-08-11 | — | — | US | disclosed |
| EP-0437016-B1 | Lipid A analogues having immunoactivating and anti-tumour activity | SANKYO CO (JP) | 1996-05-01 | — | — | EP | disclosed |
| EP-0437016-A2 | Lipid A analogues having immunoactivating and anti-tumour activity | Sankyo Company Limited (JP) | 1991-07-17 | — | — | EP | disclosed |
| US-4369311-A | Method of preparation of cyclic nitrile sulfites | THE DOW CHEMICAL COMPANY (US) | 1983-01-18 | — | — | US | disclosed |